Education
About Us
Working with TipRanks
Follow Us
Tenon Medical, Inc. (TNON)
NASDAQ:TNON
TNON Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.91 - $15.79
Previous CloseN/A
Volume74.29K
Average Volume (3M)14.62M
Market Cap
$6.94M
Enterprise Value$3.55M
Total Cash (Recent Filing)$245.63K
Total Debt (Recent Filing)$574.98K
Price to Earnings (P/E)―
Beta1.36
Next Earnings
Jun 10, 2025EPS Estimate
-0.99Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-22.80
Shares Outstanding6,199,965
10 Day Avg. Volume634,635
30 Day Avg. Volume14,615,648
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.95
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.51
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.07
Enterprise Value/Ebitda-0.27
Forecast
1Y Price Target
$3.00Price Target Upside167.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Tenon Medical, Inc. News
PremiumCompany Announcements
Tenon Medical’s Earnings Call: Cautious Optimism Amid Challenges
PremiumCompany Announcements
Tenon Medical Reports Revenue Growth and Strategic Advances
---
Bulls Say, Bears Say
Bulls Say
Growth StrategyThe company’s focus on physician training and expanding surgeon adoption should support long-term procedural growth.
Market PotentialWith a significant market opportunity and superior technology, TNON is considered undervalued, supporting a Buy rating.
Product InnovationThe anticipated mid-2025 commercial launch of the new Catamaran SE device could serve as a meaningful growth driver.
Bears Say
Market OutlookUnforeseen headwinds in receiving reimbursement from payors have caused a tempering of the 12-month outlook and a lowered price target.
Reimbursement ChallengesReimbursement uncertainty remains a key risk, leading to lower revenue estimates and a reduced price target.
Revenue PerformanceThe company's 3Q24 revenue was below expectations due to unforeseen reimbursement headwinds.
---
Ownership Overview
―
Insiders
0.10% Mutual Funds
0.41% Other Institutional Investors
99.44% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TNON FAQ
What was Tenon Medical, Inc.’s price range in the past 12 months?
Tenon Medical, Inc. lowest stock price was $0.91 and its highest was $15.79 in the past 12 months.
What is Tenon Medical, Inc.’s market cap?
Tenon Medical, Inc.’s market cap is $6.94M.
When is Tenon Medical, Inc.’s upcoming earnings report date?
Tenon Medical, Inc.’s upcoming earnings report date is Jun 10, 2025 which is in 47 days.
How were Tenon Medical, Inc.’s earnings last quarter?
Tenon Medical, Inc. released its earnings results on Mar 20, 2025. The company reported $10.53 earnings per share for the quarter, beating the consensus estimate of -$3.77 by $14.3.
Is Tenon Medical, Inc. overvalued?
According to Wall Street analysts Tenon Medical, Inc.’s price is currently Undervalued.
Does Tenon Medical, Inc. pay dividends?
Tenon Medical, Inc. does not currently pay dividends.
What is Tenon Medical, Inc.’s EPS estimate?
Tenon Medical, Inc.’s EPS estimate is -0.99.
How many shares outstanding does Tenon Medical, Inc. have?
Tenon Medical, Inc. has 6,199,965 shares outstanding.
What happened to Tenon Medical, Inc.’s price movement after its last earnings report?
Tenon Medical, Inc. reported an EPS of $10.53 in its last earnings report, beating expectations of -$3.77. Following the earnings report the stock price went down -9.91%.
Which hedge fund is a major shareholder of Tenon Medical, Inc.?
Currently, no hedge funds are holding shares in TNON
---
Company Description
Tenon Medical, Inc.
Tenon Medical, Inc. (TNON) is a medical device company operating in the healthcare sector, primarily focused on developing and commercializing innovative solutions for sacroiliac joint fusion surgery. The company aims to address unmet clinical needs in the treatment of lower back pain caused by sacroiliac joint dysfunction. Its core product, the Catamaran System, is designed to offer a minimally invasive surgical option that enhances patient outcomes and recovery times.
---
TNON Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Tenon Medical demonstrated significant improvements in revenue growth and gross margin for the full year 2024, alongside promising clinical outcomes and a strong cash position. However, challenges in the fourth quarter, including a revenue decline and ongoing reimbursement issues, suggest areas needing attention. Overall, the sentiment is cautiously optimistic with a focus on future growth and overcoming current challenges.Read More>---
TNON Stock 12 Month Forecast
Average Price Target
$3.00
▲(167.86% Upside)
Technical Analysis
Sintx Technologies
―
Biomerica
―
Aethlon Medical
―
Venus Concept
―
Autonomix Medical, Inc.
―
Best Analysts Covering TNON
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-64.36%
reiterated a buy rating last month
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -64.36% per trade.
---